The present invention relates to the treatment of otitis media, in particularly secretory otitis media, with an anti-inflammatory drug such as a steroid or a non-steroid anti-inflammatory drug, wherein said anti-inflammatory drug is formulated as a depot formulation for retroauricular injection.